Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)

Annie C. Bowles, Brittni A. Scruggs, Bruce A. Bunnell

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Multiple sclerosis (MS) is a common neurodegenerative disease that presents after an auto-reactive immune response against constituents of the central nervous system. Demyelination, infl ammation, and white matter lesions are all hallmarks of this disease. Clinical research supports the use of mesenchymal stem cells (MSCs) as therapy for MS to ameliorate symptoms and pathology. MSCs can be isolated from multiple tissues, including adipose and bone marrow, and are able to migrate to sites of pathology, release antiinfl ammatory factors, and provide immunomodulatory and neuroprotective effects once administered. Numerous studies have demonstrated the benefi cial effects of MSCs in experimental autoimmune encephalomyelitis (EAE), an induced model of MS. EAE can be induced in several species; however, the mouse is commonly used for therapeutic testing. In the following chapter, scientists will be able to learn how to prepare reagents and MSCs (e.g., isolate, culture, and expand) as well as skillfully execute induction of EAE in mice and administer stem cell-based treatments. Standard methods used to evaluate the disease progression and analyze postmortem tissues are also included.

Original languageEnglish
Pages (from-to)303-319
Number of pages17
JournalMethods in molecular biology (Clifton, N.J.)
StatePublished - 2014


  • EAE
  • Mesenchymal stem cells
  • Multiple sclerosis
  • Murine experimental autoimmune encephalomyelitis
  • Myelin oligodendrocyte glycoprotein
  • T cellmediated autoimmune disease


Dive into the research topics of 'Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)'. Together they form a unique fingerprint.

Cite this